✦ LIBER ✦

Risk factors for and pre-medications to prevent cetuximab-induced infusion reactions in patients with squamous cell carcinoma of the head and neck

✍ Scribed by Touma, Waseem; Koro, Sami S.; Ley, Jessica; Wildes, Tanya M.; Michel, Loren; Tao, Yu; Adkins, Douglas

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Population Pharmacokinetics of Cetuximab

✍ Dirks, Nathanae L.; Nolting, Arno; Kovar, Andreas; Meibohm, Bernd 📂 Article 📅 2008 🏛 Sage Publications 🌐 English ⚖ 341 KB

Risk of superficial squamous cell carcin

✍ Chikatoshi Katada; Manabu Muto; Meijin Nakayama; Satoshi Tanabe; Katsuhiko Higuc 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 423 KB

Cetuximab combined with radiotherapy: An

✍ J. Bernier; D. Schneider 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 208 KB

Risk Factors for Prolonged Diagnosis to

✍ Sharma, S.; Bekelman, J.E.; Lin, A.; Roman, B.; Mitra, N.; Swisher-McClure, S.D. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Dasatinib blocks cetuximab- and radiatio

✍ Chunrong Li; Mari Iida; Emily F. Dunn; Deric L. Wheeler 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 922 KB

Management of dermatitis in patients wit

✍ Luis Cabezón Gutiérrez; Parham Khosravi-Shahi; Yolanda Escobar Álvarez 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 167 KB